Escitalopram SIDE EFFECTS, Importer of pharmaceutical API, finished drugs, Pharmaceutical Raw Material, importer, buyer, Bulk Pharmaceuticals Company Manufacturers, Suppliers, Exporters from Taj Pharmaceuticals Ltd. (Taj Group)

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Escitalopram Hbr Taj Pharmaceuticals

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Escitalopram Hbr Manufacturers in India Suppliers Escitalopram Hbr Exporters Distributors Escitalopram Hbr api active pharmaceuticals ingredients Escitalopram Hbr manufacturers Side Effects bulk drugs raw material Escitalopram Hbr companies Side Effects Importers Escitalopram Hbr Escitalopram Hbr Exporters Escitalopram Hbr exporters FDA Escitalopram Hbr DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Escitalopram Hydrochloride manufacturing pharmaceutical drugs pharmaceutical intermediates Escitalopram Hydrochloride pharmaceutical chemicals pharmaceutical raw materials Escitalopram Hydrochloride active pharmaceutical ingredients Escitalopram Hydrochloride committee active pharmaceutical ingredients manufacturer Escitalopram Hydrochloride Active Pharmaceutical Ingredients manufacturer Escitalopram Hydrochloride exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Escitalopram Hbr, Escitalopram Hbr manufacturer India, Escitalopram Hbr product, Escitalopram Hbr products, Api preparation, Certificate of Analysis API manufacturer product, Escitalopram Hbr anti ulcer product, Certificate of Origin COA Escitalopram Hbr COS Escitalopram Hbr, pharmaceutical generic, pharmaceutical drug, medical, Escitalopram Hbr pharma healthcare, pharma patents, contract MSDS manufacturing Trader Escitalopram Hbr pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Escitalopram Hbr expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Escitalopram Hbr DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Escitalopram Hbr ingredients, api, HIV Escitalopram Hbr, tablets, capsules, syrup & protein Escitalopram Hbr powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Escitalopram Hbr gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Escitalopram Hbr WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

HOME >> API >> API List1 >> Escitalopram Hbr >> Side Effects

SIDE EFFECTS
Escitalopram CAS NO 128196-01-0

The most common side effects associated with escitalopram are agitation or restlessness, blurred vision, diarrhea, difficulty sleeping, drowsiness, dry mouth, fever, frequent urination, headache, indigestion, nausea, increased or decreased appetite, increased sweating, sexual difficulties (decreased sexual ability or desire, ejaculatory delay), taste alterations, tremor (shaking), weight changes. Although changes in sexual desire, sexual performance, and sexual satisfaction often occur as a result of depression itself, they also may be a consequence of the drugs used to treat depression. In particular, about one in 11 men given escitalopram report difficulties ejaculating.

Some patients experience withdrawal reactions upon stopping SSRI therapy. Symptoms may include dizziness, tingling, tiredness, vivid dreams, irritability, or poor mood. In order to avoid these symptoms, the dose of SSRI can be slowly reduced instead of abruptly stopped.

Antidepressants increased the risk of suicidal thinking and behavior (suicidality) in short-term studies in children and adolescents with depression and other psychiatric disorders. Anyone considering the use of escitalopram or any other antidepressant in a child or adolescent must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared with placebo in adults beyond 24 years of age. There was a reduction in risk of suicidality with antidepressants compared with placebo in adults 65 years of age and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients who are started on therapy with antidepressants should be closely observed for clinical worsening, suicidality, or unusual changes in behavior.

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE

SIDE EFFECTS >>

PRECAUTIONS

INTERACTION

PHARMALOGY

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Api Manufacturing At Taj

Acamprosate Calcium	Clomipramine Hcl	Alendronate Sodium	Clonazepam	Amitriptyline	Clopidogrel Bisulfate	Anastrozole	Danazol	Atomoxetine Hcl	Desloratadine	Balsalazide
Desmopressin Monoacetate	Bicalutamide	Divalproex Sodium	Budesonide	Dobutamine Hcl	Bupropion Hcl	Donepezil	Calcitonin	Dothiepin Hcl	Capecitabine	Entacapone
Carbamazepine	Eptifibatide	Carboplatin	Escitalopram HBr	Carisoprodol	Eszopiclone	Carvedilol	Finasteride	Cefuroxime Axetil	Flurbiprofen	Cisplatin
Fluticasone Propionate	Citalopram Hbr	Fluvoxamine Maleate	Fosphenytoin Sodium

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.